SCHEMBL18868092

SCHEMBL18868092

C=C(C)C(C)C(C)CCCNC

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KISS1R Q969F8 1/20 0.43
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25567303 0.78 KISS1R (0.46) KISS1RHTR2AHRH1EPHX1
SCHEMBL11393539 0.76
SCHEMBL3068808 0.76 ALDH1A1 (0.34)
SCHEMBL25774534 0.74 GABBR2 (0.32)
SCHEMBL19578139 0.72 KISS1R (0.40) KISS1RHTR2AHRH1EPHX1
SCHEMBL19504757 0.72 KISS1R (0.40) KISS1RHTR2AHRH1EPHX1
SCHEMBL11973508 0.72 SPHK1 (0.42)
SCHEMBL2116722 0.72 ALDH1A1 (0.34)
SCHEMBL21365187 0.71 KISS1R (0.42) KISS1RHTR2AHRH1EPHX1
SCHEMBL21276538 0.71 EPHX1 (0.39) KISS1RHTR2AHRH1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3797775-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY Novartis AG (CH) 2021-03-31 EP disclosed
EP-3167886-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA SARcode Bioscience Inc. (US) 2017-05-17 EP disclosed